The pharmaceutical industry currently experiences a trend towards continuous manufacturing as there are many advantages, including better control of process conditions, effectively eliminating batch-to-batch variability, and the lack of scale-up problems, since even bench-top continuous systems can produce the desired quantities required in the pharmaceutical or fine-chemicals industry. We present the development of continuous processes for the synthesis of active pharmaceutical ingredients (APIs).
Continuous Synthesis of Active Pharmaceutical Ingredients Using Organometallic Heterogeneous Catalysis
POLO, Eleonora;
2010
Abstract
The pharmaceutical industry currently experiences a trend towards continuous manufacturing as there are many advantages, including better control of process conditions, effectively eliminating batch-to-batch variability, and the lack of scale-up problems, since even bench-top continuous systems can produce the desired quantities required in the pharmaceutical or fine-chemicals industry. We present the development of continuous processes for the synthesis of active pharmaceutical ingredients (APIs).File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
